Dendritic cell-based approaches to induce antitumour immunity are promising, but have not shown encouraging results in clinical trials. Here the authors show that inhibition of p38 MAPK in dendritic cells increases expression of OX40L, boosting antitumour T-cell responses and dampening regulatory T-cell activity.
- Yong Lu
- Mingjun Zhang
- Qing Yi
